News
May 3, 2024
Medvasc’s patent portfolio granted in all prioritized jurisdictions
During 2023 MedVasc patent was granted in China, India, Canada, and Brazil. MedVasc’s patent portfolio is strengthened by the progression relating to the company’s medical device, the anesthesia catheter SolutioTM. SolutioTM minimizes the pain when performing the gold standard treatment methods for treating varicose veins and is expected to…
May 3, 2024
SolutioTM featured twice at 2023 Veith Symposium, NYC
MedVasc anesthesia catheter SolutioTM gained attention during 2023 Veith Symposium in NYC as renowned KOL Dr. Lowell Kabnick gave a talk on center stage about next-generation venous devices. In addition, Dr. Michael Åkesson was also invited to present the results from our first-in-man clinical study….
August 30, 2023
MedVasc selected to join accelerator powered by Medtronic
MedVasc has been selected to join prestigious medtech ac MedVasc has been selected as 1 of 11 international medtech startups to learn from Medtronic and MedLim partners how to accelerate commercialization. It all kicked off with a fantastic week in Maastricht followed by digital sessions and 1-1 meetings. “We feel humble and grateful for the opportunity. It’s been a…
August 30, 2023
Successful closing of SEK 3 million investment round
MedVasc has closed an investment round of 3 M SEK. The investors include several Life science investors such as Life Science Invest Gamma, but also existing and new private investors. The raised capital will mainly be used for final product development and for preparing an FDA 510k application for…
January 20, 2023
Medvasc’s patent portfolio has been granted in key licensing markets
In the fall of 2022, the patent authorities of India, Canada, and Brazil announced that they intend to grant MedVasc’s patent. MedVasc’s patent portfolio is strengthened by the announcements relating to the company’s medical device, the anesthesia catheter SolutioTM. SolutioTM minimizes the pain when performing the gold standard treatment…
For press inquiries, please send an email
Subscribe to our newsletter
For more information on how we process your personal data please see our Privacy Notice